Vivos management to present at 11:30 am Eastern Time on March 16, 2021 HIGHLANDS RANCH Colorado, March 1, 2021 Vivos Therapeutics, Inc. (NASDAQ: VVOS), a medical technology company focused...
Read More
Physicians and Dentists Collaborate to Offer Vivos System Treatment to Patients Suffering from Sleep Apnea HIGHLANDS RANCH Colorado, March 8, 2021 Vivos Therapeutics, Inc. (NASDAQ: VVOS), a medical technology...
Read More
VivoScore Opens the Door for More Patients to be Diagnosed and Treated for Sleep Apnea HIGHLANDS RANCH Colorado, February 16, 2021 Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical...
Read More
Obstructive Sleep Apnea is One of the Most Prevalent Diseases in the World, Affecting Approximately 1 Billion People and Contributing to Serious Comorbidities HIGHLANDS RANCH Colorado, January 29, 2021...
Read More
Vivos Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares HIGHLANDS RANCH Colorado, January 29, 2021 Vivos Therapeutics, Inc....
Read More
Obstructive Sleep Apnea is One of the Most Prevalent Diseases in the World, Affecting Approximately 1 Billion People and Contributing to Serious Comorbidities HIGHLANDS RANCH Colorado, January 5, 2021...
Read More
